HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a Buy rating on Precision BioSciences (NASDAQ:DTIL) and maintained a $3 price target.
February 14, 2024 | 6:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating on Precision BioSciences with a $3 price target.
The reiteration of a Buy rating and maintenance of a $3 price target by a reputable analyst firm like HC Wainwright & Co. could instill confidence among investors and potentially lead to a positive short-term impact on DTIL's stock price. Analyst ratings often influence investor perception and can lead to price movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100